Acute effects of nocturnal doses of MDMA on measures of impulsivity and psychomotor performance throughout the night
- PMID: 17219216
- DOI: 10.1007/s00213-006-0679-6
Acute effects of nocturnal doses of MDMA on measures of impulsivity and psychomotor performance throughout the night
Abstract
Introduction: Previous studies on the acute effects of MDMA on psychomotor performance and impulsivity showed that MDMA acts as a stimulant. These studies assessed performance during daytime, whereas in real life, dance-attendees leaving a party use the drug during the night.
Objectives: The present study aimed to assess the effects of nocturnal doses of MDMA on psychomotor performance and impulsivity during the night and after a night of sleep deprivation.
Materials and methods: Fourteen healthy subjects participated in a double-blind, placebo-controlled, two-way within-subject study. The treatment was MDMA (75 and 50 mg) divided over the evening or double placebo. Psychomotor and impulsivity tasks were conducted four times throughout the evening and night. A vigilance test was conducted once, at 5 A.M.,: and a sleepiness scale was presented to the subjects ten times throughout the evening and night.
Results: MDMA impaired tracking performance in a simple tracking task. Divided attention task performance was also impaired as indicated by a decrease in secondary task performance under the influence of MDMA compared with placebo. MDMA did not affect impulsivity measures. Vigilance performance decreased as a function of time on task, but this decrement was less during MDMA treatment compared to placebo. After the administration of MDMA, the sleepiness scale scores were lower during the night when compared with placebo. This difference between MDMA and placebo disappeared in the morning.
Conclusion: It is concluded that nocturnal doses of MDMA may produce impairments of tracking performance and divided attention throughout the night that are additive to performance impairment produced by sleep loss.
Similar articles
-
Dose-related effects of MDMA on psychomotor function and mood before, during, and after a night of sleep loss.Psychopharmacology (Berl). 2010 Mar;209(1):69-76. doi: 10.1007/s00213-009-1767-1. Psychopharmacology (Berl). 2010. PMID: 20084368 Free PMC article. Clinical Trial.
-
Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on behavioral measures of impulsivity: alone and in combination with alcohol.Neuropsychopharmacology. 2006 May;31(5):1048-55. doi: 10.1038/sj.npp.1300894. Neuropsychopharmacology. 2006. PMID: 16160704 Clinical Trial.
-
MDMA and alcohol effects, combined and alone, on objective and subjective measures of actual driving performance and psychomotor function.Psychopharmacology (Berl). 2006 Sep;187(4):467-75. doi: 10.1007/s00213-006-0434-z. Epub 2006 Jul 8. Psychopharmacology (Berl). 2006. PMID: 16830130 Clinical Trial.
-
The neuropsychology of ecstasy (MDMA) use: a quantitative review.Hum Psychopharmacol. 2007 Oct;22(7):427-35. doi: 10.1002/hup.873. Hum Psychopharmacol. 2007. PMID: 17896346 Review.
-
MDMA use and neurocognition: a meta-analytic review.Psychopharmacology (Berl). 2007 Jan;189(4):531-7. doi: 10.1007/s00213-006-0601-2. Epub 2006 Nov 3. Psychopharmacology (Berl). 2007. PMID: 17082969 Review.
Cited by
-
Sensitivity and validity of psychometric tests for assessing driving impairment: effects of sleep deprivation.PLoS One. 2015 Feb 10;10(2):e0117045. doi: 10.1371/journal.pone.0117045. eCollection 2015. PLoS One. 2015. PMID: 25668292 Free PMC article.
-
Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2 h apart.Psychopharmacology (Berl). 2013 Feb;225(4):883-93. doi: 10.1007/s00213-012-2894-7. Epub 2012 Nov 10. Psychopharmacology (Berl). 2013. PMID: 23142957 Clinical Trial.
-
Drug liking and wanting, not impulsive action or reflection is increased by 4-fluoroamphetamine.Psychopharmacology (Berl). 2018 Aug;235(8):2349-2356. doi: 10.1007/s00213-018-4931-7. Epub 2018 May 31. Psychopharmacology (Berl). 2018. PMID: 29855660 Free PMC article. Clinical Trial.
-
Pharmacological effects of methylone and MDMA in humans.Front Pharmacol. 2023 Feb 17;14:1122861. doi: 10.3389/fphar.2023.1122861. eCollection 2023. Front Pharmacol. 2023. PMID: 36873994 Free PMC article.
-
Changes in serotonin transporter (5-HTT) gene expression in peripheral blood cells after MDMA intake.Psychopharmacology (Berl). 2015 Jun;232(11):1921-9. doi: 10.1007/s00213-014-3827-4. Epub 2014 Dec 20. Psychopharmacology (Berl). 2015. PMID: 25524139
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous